Initial clinical experience with allopurinol-thiopurine combination therapy in pediatric inflammatory bowel disease

Abstract

Combination therapy successfully shunted thiopurine metabolites to a more favorable pattern. Reversible neutropenia was the most common side effect (2 patients). Long-term prospective studies are needed in this patient population.